ArticleEffect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study
Section snippets
Dr Fadini obtained his speciality in Gynaecology and Obstetrics and in Human Reproduction from the University of Milan, Italy. From 1985 to 1999 he directed the Unit of Reproductive Medicine and Endocrinology at San Gerardo University Hospital in Monza, University of Milan. He is Assistant Professor in the School of Specialization in Gynaecology and Obstetrics and at the School of Medical Biotechnologies, Faculty of Medicine, University of Milan-Bicocca. He has been Director of the Unit of
References (44)
- et al.
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone
Lancet
(1985) - et al.
The new Italian IVF legislation
Reproductive BioMedicine Online
(2004) - et al.
Obstetric outcome of patients with polycystic ovary syndrome treated by in-vitro maturation and in-vitro fertilization–embryo transfer
Fertility and Sterility
(2005) - et al.
Pregnancies and deliveries after in-vitro maturation culture followed by in-vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome
Fertility and Sterility
(2000) In-vitro maturation of immature oocytes for infertile women with PCOS
Reproductive BioMedicine Online
(2004)- et al.
In-vitro maturation of human oocytes
Reproductive BioMedicine Online
(2004) - et al.
Pregnancies resulting from in-vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin
Fertility and Sterility
(1999) - et al.
Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in-vitro maturation of oocytes program
Fertility and Sterility
(2003) - et al.
A comparison of in-vitro maturation and in-vitro fertilization for women with polycystic ovaries
Obstetrics and Gynecology
(2002) - et al.
In-vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome
Fertility and Sterility
(2001)
Maturation in-vitro of human ovarian oocytes
Lancet
Influence of human menopausal gonadotropin on the recruitment of human ovarian follicles
Fertility and Sterility
Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in-vitro maturation
Fertility and Sterility
What is the smallest size of follicle to respond to human chorionic gonadotropin injection?
Fertility and Sterility
Strategies in human in-vitro maturation and their clinical outcome
Reproductive BioMedicine Online
Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming
Fertility and Sterility
Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in-vitro maturation of human cumulus-enclosed oocytes
Fertility and Sterility
Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS
Reproductive BioMedicine Online
In-vitro maturation of eggs: is it really useful?
Best Practice and Research. Clinical Obstetrics and Gynaecology
The revised CONSORT statement for reporting randomized trials: explanation and elaboration
Annals of Internal Medicine
Human chorionic gonadotropin for in-vitro oocyte maturation: does it improve the endometrium or implantation?
The Journal of Reproductive Medicine
Cited by (0)
Dr Fadini obtained his speciality in Gynaecology and Obstetrics and in Human Reproduction from the University of Milan, Italy. From 1985 to 1999 he directed the Unit of Reproductive Medicine and Endocrinology at San Gerardo University Hospital in Monza, University of Milan. He is Assistant Professor in the School of Specialization in Gynaecology and Obstetrics and at the School of Medical Biotechnologies, Faculty of Medicine, University of Milan-Bicocca. He has been Director of the Unit of Gynaecology and Obstetrics and Chief of the BIOGENESI Reproductive Medicine Centre at the Istituti Clinici Zucchi, in Monza since 2000.
Declaration: The authors report no financial or commercial conflicts of interest.